An investigation for investors in NYSE:FMS shares was announced concerning possible violations of securities laws by Fresenius Medical Care AG & Co. and certain of its directors and officers.
Investors who purchased shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Fresenius Medical Care AG & Co. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Fresenius Medical Care AG & Co. reported that its annual Total Revenue rose from over $15.83 billion in 2014 to over $16.73 billion in 2015 and that its Net Income declined from over $1.04 billion in 2014 to over $1.02 billion in 2015.
Shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) reached as high as $47.09 per share in August 2016.
On January 7, 2017, Fresenius Medical Care AG & Co. reported that its U.S. unit had received subpoenas from federal prosecutors seeking information on the Company’s ties with the American Kidney Fund, a charity that helps patients pay for kidney dialysis.
Shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) closed on January 23, 2017 at $40.40 per share.
Those who purchased NYSE:FMS shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Leave Your Comments